Patheon sells global secondary clinical packaging services business to Bellwyck
Patheon Inc said it has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions.
The company Bellwyck Solutions is a private company engaged in providing clinical trial and contract services for secondary packaging.
Patheon’s Chief Executive Officer, James C Mullen said, “We are very happy to have reached an agreement with Bellwyck for this business.”
Mr. Mullen also said, “While we don’t expect the terms of the transaction to have a material impact on our on-going results, this transaction is part of our continued focus on our core competencies of solid-dose and parenteral development and manufacturing. One of Bellwyck’s core competencies is clinical packaging. We are confident that both the customers and our employees, about 20 of whom have joined Bellwyck, are in good hands.”
Bellwyk’s Co-CEO Jeff Sziklai said, “We look forward to an ongoing partnership with Patheon as we work together to ensure that Bellwyck continues to provide superior clinical packaging and distribution services to Patheon’s current and future customers. We anticipate a seamless transition for customers and employers.”
Patheon Inc is a leading provider of contract development and manufacturing services to the global pharma industry. It is engaged in providing high quality products and services to 300 of the world’s leading pharmaceutical and biotechnology companies.
